Temporal Trends, Outcomes, and Predictors of Next‐Day Discharge and Readmission Following Uncomplicated Evolut Transcatheter Aortic Valve Replacement: A Propensity Score–Matched Analysis
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.123.033846 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Wayne B Batchelor und 9 weiteren Autor:innen. Beteiligte Einrichtung: Inova Schar Heart and Vascular Falls Church VA USA. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Patient Readmission, Propensity Score, Aortic Valve Stenosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background Next‐day discharge (NDD) outcomes following uncomplicated self‐expanding transcatheter aortic valve replacement have not been studied. Here, we compare readmission rates and clinical outcomes in NDD versus non‐NDD transcatheter aortic valve replacement with Evolut. Methods and Results Society of Thoracic Surgeons/American College of Cardiology TVT (Transcatheter Valve Therapy) Registry patients (n=29 597) undergoing elective transcatheter aortic valve replacement with self‐expanding supra‐annular valves (Evolut R, PRO, and PRO+) from July 2019 to June 2021 were stratified by postprocedure length of stay: ≤1 day (NDD) versus >1 day (non‐NDD). Propensity score matching was used to compare risk adjusted 30‐day readmission rates and 1‐year outcomes in NDD versus non‐NDD, and multivariable regression to determine predictors of NDD and readmission. Between the first and last calendar quarter, the rate of NDD increased from 45.4% to 62.1% and median length of stay decreased from 2 days to 1. Propensity score matching produced relatively well‐matched NDD and non‐NDD cohorts (n=10 549 each). After matching, NDD was associated with lower 30‐day readmission rates (6.3% versus 8.4%; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Inova Schar Heart and Vascular Falls Church VA USA.
- OhioHealth Riverside Methodist Hospital Columbus OH USA.
- Valve Science Center Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital Minneapolis MN USA.
- Structural Heart Program, Wellspan York Hospital York PA USA.
- Mid-Atlantic Permanente Medical Group McLean VA USA.
- Division of Cardiology Mount Sinai Medical Center New York NY USA.
ORCID-Profile: Wayne B Batchelor, Carlos E Sanchez, Paul Sorajja, Anapoorna Kini, Patricia Keegan, Kendra J Grubb, Ruth Eisenberg, Toby Rogers
Zitieren
APA
Batchelor, W. B., Sanchez, C. E., Sorajja, P., Harvey, J. E., Galper, B. Z., Kini, A., Keegan, P., Grubb, K. J., Eisenberg, R., & Rogers, T. (2024). Temporal Trends, Outcomes, and Predictors of Next‐Day Discharge and Readmission Following Uncomplicated Evolut Transcatheter Aortic Valve Replacement: A Propensity Score–Matched Analysis. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.033846
Vancouver
Batchelor WB, Sanchez CE, Sorajja P, Harvey JE, Galper BZ, Kini A, et al. Temporal Trends, Outcomes, and Predictors of Next‐Day Discharge and Readmission Following Uncomplicated Evolut Transcatheter Aortic Valve Replacement: A Propensity Score–Matched Analysis. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.033846
BibTeX
@article{Batchelor2024,
author = {Batchelor, Wayne B and Sanchez, Carlos E and Sorajja, Paul and Harvey, James E and Galper, Benjamin Z and Kini, Anapoorna and Keegan, Patricia and Grubb, Kendra J and Eisenberg, Ruth and Rogers, Toby},
title = {Temporal Trends, Outcomes, and Predictors of Next‐Day Discharge and Readmission Following Uncomplicated Evolut Transcatheter Aortic Valve Replacement: A Propensity Score–Matched Analysis},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.123.033846}
}
EUVIMED